SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Yeo, T.
Right arrow Articles by Lewis, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeo, T.
Right arrow Articles by Lewis, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells

TK Yeo

Section of Clinical Pharmacology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA

J Kintner

Department of Pharmacology and Toxicology, Dartmouth Medical School and Dartmouth, Lebanon, NH 03756, USA

R Armand

Section of Clinical Pharmacology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA

R Perez

Department of Pharmacology and Toxicology, Dartmouth Medical School and Dartmouth, Lebanon, NH 03756, USA; Section of Hematology/Oncology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA

LD Lewis

Section of Clinical Pharmacology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA; Department of Pharmacology and Toxicology, Dartmouth Medical School and Dartmouth, Lebanon, NH 03756, USA

2',2'-Difluorodeoxycytidine (gemcitabine), a pyrimidine nucleoside analog, is used therapeutically in the treatment of pancreatic, non-small cell lung, and breast cancer. The cytotoxic effect of gemcitabine is thought to be due to masked chain termination after the triphosphorylated anabolite of the drug is incorporated into nascent DNA strands. We tested the hypothesis that sublethal concentrations of gemcitabine inhibit DNA polymerase {gamma} and reduce mitochondrial DNA content in BxPC-3 and MOLT-4 cell lines, and we used 2',3'-dideoxycytidine, a known inhibitor of DNA polymerase {gamma} as a positive control. The 6-day BxPC-3 cell growth IC50 for gemcitabine and 2',3'-dideoxycytidine was 0.003 µM (SD ± 0.0005) and 14.5 µM (SD ± 4.7), respectively, and in MOLT-4 cells was 0.002 µM (SD ± 0.001) and 0.86 µM (SD ± 0.23), respectively. These drug concentrations were anti-proliferative but non-cytotocidal. Electron photomicrographic studies showed deranged mitochondrial cristae patterns in BxPC-3 cells treated with either gemcitabine or 2',3'-dideoxycytidine for 6 days. Mitochondrial oxidative phosphorylation dysfunction was observed as reflected by increased lactate concentration in the media of cells exposed to gemcitabine, but to a much greater extent in cells exposed to 2',3'-dideoxycytidine. PCR analysis showed that gemcitabine did not reduce mitochondrial DNA content in either BxPC-3 or MOLT-4 cells, but 2',3'-dideoxycytidine did. The effect of gemcitabine on mitochondrial ultrastructure and function did not concomitantly yield a reduction in mitochondrial DNA content. Therefore, the molecular target(s) by which gemcitabine and 2',3'-dideoxycytidine produce mitochondrial abnormalities in these cells appear to be different.

Key Words: 2',3'-dideoxycytidine • BxPC-3 • MOLT-4 • gemcitabine • mitochondria

References

  • 1 Van Moorsel CJA; Peters GJ; Pinedo HM;. Gemcitabine: future prospects of single-agent and combination studies. Oncologist 1997; 2: 127 – 134 .[Abstract/Free Full Text]
  • 2 Carmichael J. The role of gemcitabine in the treatment of other tumours. Br J Cancer 1998; 78: 21 – 25 .[Web of Science][Medline] [Order article via Infotrieve]
  • 3 Mini ENobili SCaciagli BLandini IMazzei T. Cellular pharmacology of gemcitabine. Ann Oncol 2006; 17 (Suppl. 5): v7 – v12 .[Abstract/Free Full Text]
  • 4 Heinemann VHertel LWGrindey GBPlunkett W. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Cancer Res 1988; 48: 4024 – 4031 .[Abstract/Free Full Text]
  • 5 Plunkett WHuang PXu Y-ZHeinemann VGrunewald RGandhi V. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol 1995; 22: 3 – 10 .[Web of Science][Medline] [Order article via Infotrieve]
  • 6 Plunkett WGandhi VSherri CNowak BHeinemann VMineishi S. 2',2'-Difluorodeoxycytidine metabolism and mechanism of action in human leukemia cells. Nucleosides Nucleotides 1989; 8: 775 – 785 .[CrossRef][Web of Science]
  • 7 Huang PChubb SHertel LWGrindey GBPlunkett W. Action of 2',2'-difluorodeoxycytidine on DNA synthesis. Cancer Res 1991; 51: 6110 – 6117 .[Abstract/Free Full Text]
  • 8 Heinemann VXu Y-ZChubb SSen AHertel LWGrindey GB. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine. Mol Pharmacol 1990; 38: 567 – 572 .[Abstract]
  • 9 Bouffard DYLaliberte JMomparler RL. Kinetic studies on 2',2'-difluorodeoxycytidine (gemcitabine) with purified hyman deoxycytidine kinase and cytidine deaminase. Biochem Pharmacol 1993; 45: 1857 – 1861 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 10 Van Moorsel CJA; Bergman AM; Veerman G; Voorn DA; Haperen VWTRv; Kroep JR; . Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines Biochim Biophys Acta 2000; 1474: 5–12.
  • 11 Pauwels BKorst AECPattyn GGOLambrechts HAJBockstaele DRVVermeulen K. Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro. Int J Radiat Oncol Biol Phys 2003; 57: 1075 – 1083 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 12 Morgan MAParsels LAParsels JDMesiwala AKMaybaum JLawrence TS. Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine. Cancer Res 2005; 65: 6835 – 6842 .[Abstract/Free Full Text]
  • 13 Ferreira CGSpan SWPeters GJKruyt FAEGiaccone G. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res 2000; 60: 7133 – 7141 .[Abstract/Free Full Text]
  • 14 Christgen MSchniewind BJueschke AUngefroren HKalthoff H. Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells. Cancer Lett 2005; 227: 193 – 200 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 15 Nabhan CGajria DKrett NLGandhi VGhias KRosen ST. Caspase activation is required for gemcitabine activity in multiple myeloma cell lines. Mol Cancer Ther 2002; 1: 1221 – 1227 .[Abstract/Free Full Text]
  • 16 Schniewind BChristgen MKurdow RHaye SKremer BKalthoff H. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. Int J Cancer 2004; 109: 182 – 188 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 17 Pourquier PGioffre CKohlhagen GUrasaki YGoldwasser FHertel LW. Gemcitabine (2',2'-difluoro-2'-deoxycitidine), and antimetabolite that poisons topoisomerase I. Clin Cancer Res 2002; 8: 2499 – 2504 .[Abstract/Free Full Text]
  • 18 Spengler ULichterfeld MRockstroh JK. Antiretroviral drug toxicity – a challenge for the hepatologist? J Hepatol 2002; 36: 283 – 294 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 19 Bica IMcGovern BDhar RStone DMcGowan KScheib R. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32: 492 – 497 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 20 Lewis WDalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med 1995; 1: 417 – 422 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 21 Chen C-HCheng Y-C. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. J Biol Chem 1989; 264: 11,934 – 11,937 .[Abstract/Free Full Text]
  • 22 Lewis LDHamzeh FMLietman PS. Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-Dideoxycytidine. Antimicrob Agents Chemother 1992; 36: 2061 – 2965 .[Abstract/Free Full Text]
  • 23 Lewis WGonzalez BChomyn APapoian T. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 1992; 89: 1354 – 1360 .[Web of Science][Medline] [Order article via Infotrieve]
  • 24 Medina DJTsai C-HHsiung GDCheng Y-C. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrob Agents Chemother 1994; 38: 1824 – 1828 .[Abstract/Free Full Text]
  • 25 Aponte-Cipriani SLTeplitz CYancovitz S. Pancreatitis possibly related to 2'-3'-dideoxycytidine. Ann Intern Med 1993; 119: 539 – 540 .[Free Full Text]
  • 26 Green DRReed JC. Mitochondria and apoptosis. Science 1998; 281: 1309 – 1312 .[Abstract/Free Full Text]
  • 27 Eastman A. Assays for DNA fragmentation, endonucleases, and intracellular pH and Ca2+ associated with apoptosis. Methods Cell Biol 1995; 46: 41 – 55 .[Web of Science][Medline] [Order article via Infotrieve]
  • 28 Armand RChannon JYKintner JWhite KAMiselis KAPerez RP. The effects of ethidium bromide induced loss of mitochondrial DNA on mitochondrial phenotype and ultrastructure in a human leukemia T-cell line (MOLT-4 cells). Toxicol Appl Pharmacol 2004; 196: 68 – 79 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 29 Lawrence TSChang EYHahn TMHertel LWShewach DS. Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine. Int J Radiat Oncol Biol Phys 1996; 34: 867 – 872 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 30 Yip-Schneider MTSweeney CJJung SHCrowell PLMarshall MS. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther 2001; 298: 976 – 985 .[Abstract/Free Full Text]
  • 31 Georgieva MCKonstantinov SMTopashka-Ancheva MBerger MR. Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells. Cancer Lett 2002; 182: 163 – 174 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 32 King MEGodman GCKing DW. Respiratory enzymes and mitochondrial morphology of Hela and L cells treated with chloramphenicol and ethidium bromide. J Cell Biol 1972; 53: 127 – 142 .[Abstract/Free Full Text]
  • 33 Lewis WPapoian TGonzalez BLouie HKelley DPPayne RM. Mitochondrial ultrasructural and molecular changes induced by zidovudine in rat hearts. Lab Invest 1991; 65: 228 – 236 .[Web of Science][Medline] [Order article via Infotrieve]
  • 34 Hackenbrock CR. Ultrastructural bases for metabolically linked mechanical activity in mitochondria. J Cell Biol 1966; 30: 269 – 297 .[Abstract/Free Full Text]
  • 35 Goyer RAKrall R. Ultrastructural transformation in mitochondria isolated from kidneys of normal and lead-intoxicated rats. J Cell Biol 1969; 41: 393 – 400 .[Abstract/Free Full Text]
  • 36 Hackenbrock CRRehn TGWeinbach ECLemasters J. Oxidative phosphorylation and ultrastructural transformation in mitochondria in the intact ascites tumor cell. J Cell Biol 1971; 51: 123 – 137 .[Abstract/Free Full Text]
  • 37 Rossignol RGilkerson RAggeler RYamagata KRemington SJCapaldi RA. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 2004; 64: 985 – 993 .[Abstract/Free Full Text]
  • 38 Heintz NHHamlin JL. In vivo effects of cytosine arabinoside on deoxyribonucleic acid replication in Chinese Hamster Ovary Cells. 1. Resolution of defferential effects on mitochondrial and nuclear deoxyribonucleic acid synthesis. Biochemistry 1983; 22: 3552 – 3557 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 39 Muus PBogert CVdVries HDPennings AHoltrop MHaanen C. 1-beta-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cells. Br J Cancer 1991; 64: 29 – 34 .[Web of Science][Medline] [Order article via Infotrieve]
  • 40 Miura SIzuta S. DNA polymerases as targets of anticancer nucleosides. Curr Drug Targets 2004; 5: 191 – 195 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 41 Starnes MCCheng Y-c. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J Biol Chem 1987; 262: 988 – 991 .[Abstract/Free Full Text]
  • 42 Carrasco DAStraten MVTyring SK. A review of antiretroviral drugs. Dermatol Ther 2000; 13: 305 – 317 .[CrossRef]
  • 43 Pauwels BKorst AECLardon FVermorken JB. Combined modality therapy of gemcitabine and radiation. Oncologist 2005; 10: 34 – 51 .[Abstract/Free Full Text]

Human & Experimental Toxicology, Vol. 26, No. 12, 911-921 (2007)
DOI: 10.1177/0960327107086513
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J ANIM SCIHome page
F. Liu, J. Yin, M. Du, P. Yan, J. Xu, X. Zhu, and J. Yu
Heat-stress-induced damage to porcine small intestinal epithelium associated with downregulation of epithelial growth factor signaling
J Anim Sci, June 1, 2009; 87(6): 1941 - 1949.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Yeo, T.
Right arrow Articles by Lewis, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeo, T.
Right arrow Articles by Lewis, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement